Connect with us

Published

on

GE Healthcare booth is seen ahead of the 2022 China International Fair for Trade in Services (CIFTIS) at China National Convention Center on August 28, 2022 in Beijing, China. 

Yi Haifei | China News Service | Getty Images

GE HealthCare on Monday announced a new artificial intelligence application it said will save time for doctors who diagnose and treat cancer.

CareIntellect for Oncology, as the tool is called, will help oncologists get up to speed on a patient’s history and disease progression by quickly showing them the data they need, the company said. GE said it wants to spare oncologists the headache of digging through records so they can focus on caring for their patients.   

Health-care data is notoriously difficult to analyze, and as much as 97% of the data produced by hospitals goes unused, according to a Deloitte report. That information is stored across numerous vendors and file formats such as images, lab test results, clinical notes and device readings, which can be extremely taxing for doctors to sort through. 

“It’s very time-consuming, very frustrating for these clinicians,”  Dr. Taha Kass-Hout, GE HealthCare’s global chief science and technology officer, told CNBC in an interview.

CareIntellect for Oncology will be able to summarize clinical reports and identify when patients are deviating from their treatment plans, Kass-Hout said. The system can flag when a patient misses a lab test, for instance, so that their doctor can determine the best next steps. 

“For cancer patients, the treatment journey can last years and involve numerous doctor visits,” he said.

GE HealthCare’s CareIntellect for Oncology

Courtesy of GE HealthCare

CareIntellect for Oncology can also help identify relevant clinical trials that patients might be eligible for, saving oncologists hours of work, said Chelsea Vane, vice president of digital products at GE HealthCare. That process has traditionally required doctors to scroll through a database of available trials, memorize inclusion and exclusion criteria and dig through patient records to determine a good fit, Vane told CNBC.

“What we’ve done is remove that,” she said.

The purpose of the new app is to save oncologists time and effort, but if doctors want to dive into more detail, CareIntellect for Oncology allows them to view the original record that’s referenced, the company said.

GE HealthCare is planning to make CareIntellect for Oncology widely available to U.S. customers in 2025, and it will initially be optimized for prostate and breast cancers. Health organizations such as Tampa General Hospital are already evaluating it, the company said. Since the tool is cloud-based, it will drive recurring revenue for GE HealthCare, Kass-Hout said. 

The company is planning to introduce additional apps under the CareIntellect brand in the future, Kass-Hout said. The oncology tool is the first offering, and health-care organizations will be able to easily pick and choose the apps that they want to enable, he added.  

GE HealthCare is also hoping to integrate its CareIntellect products with some of the other early stage AI initiatives it teased on Monday.   

The company highlighted five new AI products that it is developing, including a collaborative team of AI agents, a tool to predict an aggressive type of breast cancer recurrence, and a tool to flag suspicious mammography scans to radiologists more quickly. 

GE HealthCare decided to preview the new tools to give customers an idea of the problems it’s trying to solve, Kass-Hout said. The company will solicit feedback from health-care organizations and work with regulators as necessary, he said. 

For instance, GE HealthCare is exploring how a group of AI agents can work together as a team to support doctors through its tool called Health Companion.

The agents in Health Companion will be trained as experts in specific domains, such as radiology, pathology or genomics, and offer insights based on their expertise, Kass-Hout said. The agents could identify whether a specific symptom is a side effect of treatment or a sign of disease progression, for example, and suggest next steps, he added. 

Ideally, the tool will give doctors the same kind of support they’d expect from working with a multidisciplinary team, Kass-Hout said. But while consulting a panel of experts can take days or weeks, Health Companion would be available immediately. 

“At the moment, it’s an early concept,” he said. “Our aim is to elevate the standard of care and get ahead of the overburden of clinicians trying to take care of their patient.”

WATCH: The Pulse of AI in Health Care

The Pulse of AI in Health Care

Continue Reading

Technology

Figma stock pops in second day of trading after colossal debut

Published

on

By

Figma stock pops in second day of trading after colossal debut

Figma celebrates its initial public offering at the New York Stock Exchange on July 31, 2025.

NYSE

Shares of design software vendor Figma popped 6% on Friday, a day after the stock more than tripled in its New York Stock Exchange debut. 

Figma opened at $85 on Thursday under the ticker FIG, and shares closed at $115.50 for a 250% gain. On Friday, the stock traded above $120.

Figma is the latest tech company to hit the public markets after an extended IPO drought. Artificial intelligence infrastructure provider CoreWeave debuted in March, followed by the digital physical therapy company Hinge Health in May.

The stablecoin issuer Circle, virtual chronic care company Omada Health and the online banking services provider Chime all went public in June.

Read more CNBC tech news

In an update to its prospectus last week, Figma said it would price shares at $25 to $28 each. On Monday, it issued another update and said it expected pricing between $30 and $32. The company ultimately priced shares $1 above that range.

Figma, founded in 2012, almost had a very different story.

Adobe tried to buy the company for $20 billion in 2022, but after U.K. regulators said the acquisition would likely harm competition, the deal fell apart the following year.

The San Francisco-based company ranked 45th on CNBC’s 2025 Disruptor 50 list of private companies.

–CNBC’s Jordan Novet contributed to this report

WATCH: Figma more than triples in NYSE debut after selling shares at $33

Figma more than triples in NYSE debut after selling shares at $33

Continue Reading

Technology

Amazon stock sinks 7% after earnings: Here are the key takeaways

Published

on

By

Amazon stock sinks 7% after earnings: Here are the key takeaways

Amazon CEO Andy Jassy looks on during an Amazon Devices launch event in New York City, U.S., February 26, 2025. REUTERS/Brendan McDermid

Brendan Mcdermid | Reuters

Amazon on Thursday reported second-quarter earnings that beat expectations on most metrics, but the results weren’t good enough to please Wall Street.

Amazon stock slid following the release and throughout the conference call. Shares were down about 7% Friday.

Profit guidance was weaker than expected, while cloud growth underwhelmed investors.

That overshadowed an otherwise upbeat report that included strong revenue and profits, steady retail growth and a 23% increase in advertising sales. Amazon also offered a rosy revenue forecast for the current quarter.

Here are three key takeaways from Amazon’s earnings:

AI spending boost

Amazon reported that it spent $31.4 billion on capital expenses in the last quarter, and the company expects that to be “reasonably representative” of its spending in the second half of the year. In the first quarter, Amazon’s capital expenditures exceeded $24 billion.

Taken together, it means that Amazon could spend an upwards of $118 billion on capital expenditures this year, up from its previous forecast of $100 billion. Amazon’s capex, which hit $83 billion a year ago, is primarily going toward building out tech infrastructure to support artificial intelligence demand.

Amazon’s competitors are also throwing big money at AI.

On Wednesday, Meta lifted its forecast for capital spending to a range of $66 billion to $72 billion. Google parent Alphabet raised its capital spend last week to $85 billion this year.

The question on investors’ minds is when these big AI bets will begin to pay off in revenue or profit.

Amazon boosts capex to more than $118 billion as AI cloud arms race heats up

Amazon CEO Andy Jassy hinted the company’s progress on AI has improved its “operational efficiency and business growth,” but offered few specifics beyond that.

Amazon has also said previously that generative AI is contributing revenue to AWS at an annualized rate equivalent to “multiple billions of dollars.”

On a conference call with investors, Jassy pointed to Alexa+, an upgraded version of its digital assistant, as a way it could monetize AI. The service, which launched in early access in late March, is $19.99 a month, or free for Prime members.

“I think over time, you could also imagine, as we keep adding functionality that there could be some sort of subscription element beyond what there is today,” Jassy said.

Jassy reiterated that it’s “very early days” in AI development and adoption.

Cloud rivals

Amazon Web Services continues to lead the cloud infrastructure market, but it’s facing steeper competition from Microsoft Azure and Google Cloud, which posted stronger growth rates in their latest quarterly results.

AWS grew its revenue by 18% year over year, which just beat Wall Street’s estimates. That trailed the big gains reported by Microsoft and Alphabet. The companies recorded cloud growth rates of 39% and 32%, respectively.

Analysts asked Amazon leadership on the call why its cloud business isn’t growing as quickly as its rivals.

“There is a Wall Street finance person narrative right now that AWS is falling behind in generative AI with concerns about share loss to peers, etcetera,” said Morgan Stanley analyst Brian Nowak. The firm has an overweight rating on Amazon’s stock.

Attendees walk through an exposition hall at AWS re:Invent, a conference hosted by Amazon Web Services, in Las Vegas on Dec. 3, 2024.

Noah Berger | Getty Images

JPMorgan analyst Doug Anmuth said there’s been “significantly faster cloud growth among the number two and number three players in the space.”

Jassy said sometimes the company is growing faster than rivals, and vice versa, but AWS still has a “meaningfully larger” cloud business.

“I think the second player is about 65% of the size of AWS,” he said.

Jassy also appeared to take a swipe at Microsoft over a recent worldwide attack on its SharePoint collaboration software, saying AWS customers see a “very big difference” in security.

“You could just look at what’s happened the last couple months, you can just see kind of adventures at some of these players almost every month,” Jassy said.

The comments failed to sway some investors.

Bernstein analysts said Friday that the “tone wasn’t great” and Amazon’s explanation for its competitive positioning and trajectory “sounded less constructive than peers.”

“Words matter…but numbers matter more,” the analysts wrote.

Tariff risk better than feared

In May, Amazon warned it was bracing for potential uncertainty ahead linked to President Donald Trump‘s shifting tariff and trade policies.

At the time, products imported from China were subject to a steep 145% levy. That threatened to drive up costs for Amazon vendors and its millions of third-party sellers, raising concerns of price increases and a drop-off in consumer demand.

Since then, the U.S. and China have reached a truce, with China now facing a 30% combined tariff rate.

Amazon’s latest earnings showed the company seems to be navigating the tariffs and shifting trade policies better than Wall Street had feared.

Sales in its online store topped analysts projections and grew 11% year over year, while seller services revenue also beat expectations. The number of items sold in Amazon’s online and physical stores jumped 12%, indicating that the consumer remains “healthy” despite tariffs and economic uncertainty, analysts at Citizens wrote in a Friday note to clients.

Amazon’s third-quarter sales forecast, which implies 13% growth at the high end, suggests “tariffs appear to have been effectively absorbed by suppliers, merchants and customers,” Citizens analysts wrote. They have an outperform rating on the company’s shares.

Jassy struck a positive but cautious tone on the call, saying it’s “hard to know” where the tariffs will settle, especially when it comes to China.

“We’re unsure at this point who’s going to end up absorbing those higher costs,” he said.

A deal between the U.S. and China hasn’t been finalized, and the two countries have until Aug. 12 to reach a final agreement.

So far, Amazon has been able to weather Trump’s trade war.

“We just haven’t seen diminished demand, and we haven’t seen any kind of broad scale [average selling price] increases,” Jassy said on the call. “So that could change in H2. There are a lot of things that we don’t know, but that’s what we’ve seen so far.”

Read more CNBC tech news

Continue Reading

Technology

Joby, L3Harris partner on hybrid defense craft that can be piloted or autonomous

Published

on

By

Joby, L3Harris partner on hybrid defense craft that can be piloted or autonomous

An electric air taxi by Joby Aviation sits at the Downtown Manhattan Heliport in New York City, Nov. 12, 2023.

Roselle Chen | Reuters

Joby Aviation and defense manufacturing giant L3Harris announced a partnership Friday to develop a next-generation military craft that can be piloted or fly autonomously.

The partnership brings together Joby’s hybrid vertical take-off and landing, or VTOL, aircraft and L3’s expertise in military systems and certification.

The companies expect to begin testing this fall, followed by operational demonstrations in 2026, according to the release.

“Conflicts like Russia, Ukraine, are really changing how people think about, you know, low altitude aviation generally,” Joby executive chairman Paul Sciarra told CNBC’s Morgan Brennan. “Getting something out there that can move very quickly from demonstration to deployability felt especially important.”

Jon Rambeau, president of Integrated Mission Systems at L3Harris, said initially the project will focus on use cases like airborne surveillance, reconnaissance and contested logistics applications.

“We’re going to target … the broader government exercises that the military services hold periodically, and see if we can fit some of those use cases into those larger exercises,” Rambeau told Brennan.

Read more CNBC tech news

The announcement comes as government spending is under scrutiny and the U.S. military works to bolster the technology in battlefield operations, adding artificial intelligence with autonomous vehicles and drones.

“I think the branches are questioning whether or not you know the right approach for low altitude support is, you know, $30 million crude Apaches, or whether or not it’s something that is smaller, cheaper and autonomous — it has the ability to adapt to flexible payloads,” Sciarra said.

Joby is known for its commercial air taxis, which are electric. The company delivered its first electric vertical takeoff and landing, or eVTOL, aircraft to the United Arab Emirates at the end of June, where it is working toward a 2026 launch.

The new military vehicle with L3, based on Joby’s S4 craft, will be developed with a gas turbine, according to the release.

Joby, which is still working on Federal Aviation Administration approval for its aircraft, recently announced an expansion of manufacturing and hopes to double production at its California hub.

Shares of Joby are up more than 100% this year. L3Harris stock is up 30% so far in 2025.

The Army is testing 40+ new technologies on the battlefield

Continue Reading

Trending